Analyst initiations: CYPB, BAC, PODD, TLEO and VOCS
Posted Oct 2nd 2007 11:07AM by Eric Buscemi
Filed under: Analyst Reports, Bank of America (BAC), Analyst Initiations
.gif)
MOST NOTEWORTHY: Cypress Bioscience, Banc of America, Insulet, Taleo and Vocus Inc were today's noteworthy initiations:
- Friedman Billings started shares of Cypress Biosciences Inc (NASDAQ: CYPB) with an Outperform rating and $22 target, and is positive on the company's lead product milnacipran, in Phase III studies for fibromyalgia. The firm expects a 1Q09 launch and believes the U.S. market could be as large as $7B.
- Goldman resumed coverage of Bank of America Corporation (NYSE: BAC) with a Buy rating and $63 target as they believe the company has around $22.5B of unrealized gains in its strategic investment portfolio. Goldman also added BAC to their Americas Buy List.
- Insulet Corporation (NASDAQ: PODD) was initiated at William Blair with an Outperform rating. The firm believes the unique features of the OmniPod will allow PODD to capture a meaningful portion of the 300,000 current insulin pumpers in the United States.
- Soleil started shares of Taleo Corporation (NASDAQ: TLEO) with a Buy rating and $35 target and believes the company's recent growth pace can continue.
- Shares of Vocus Inc (NASDAQ: VOCS) were also initiated at Soleil with a Buy rating and $39 target. The firm believes the company can gain share in the early stage market for public relations software given its on-demand model and low price entry point.
OTHER INITIATIONS:
Tags: BAC, Banc of America, BancOfAmerica, CYPB, Cypress Biosciences, CypressBiosciences, Dreamworks, DWA, initiation, initiations, Insulet, LGF, Lions Gate, LionsGate, Marvel Entertainment, MarvelEntertainment, MVL, Nintendo, NTDOY, PODD, Taleo, TLEO, VOCS, Vocus
Closing Bell: When We All Love the PIIGS (NBG, SQNM, PG, ERTS, KO)
Serious Money: Cheapest Stocks List Shrinks from 26 to 21
Chasing Value: Hasbro Earnings Makes My Point
